“Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus With Multiple Cardiovascular Risk Factors”. Cardiology and Cardiovascular Medicine 7, no. 2 (April 24, 2023): 141–144. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16403.